Treatment for childhood acute lymphoblastic leukemia in Taiwan: Taiwan Pediatric Oncology Group ALL-2002 study emphasizing optimal reinduction therapy and central nervous system preventive therapy without cranial radiation

详细信息    查看全文

• 作者：Meng-Ju Li ; Hsi-Che Liu ; Hsiu-Ju Yen ; Tang-Her Jaing ; Dong-Tsamn Lin ; Chao-Ping Yang ; Kai-Hsin Lin ; Iou-Jih Hung ; Shiann-Tarng Jou ; Meng-Yao Lu ; Chih-Cheng Hsiao ; Ching-Tien Peng ; Tai-Tsung Chang ; Shih-Chung Wang ; Ming-Tsan Lin ; Jiann-Shiuh Chen ; Te-Kau Chang ; Giun-Yi Hung ; Kang-Hsi Wu ; Yung-Li Yang ; Hsiu-Hao Chang ; Shih-Hsiang Chen ; Ting-Chi Yeh ; Chao-Neng Cheng ; Pei-Chin Lin ; Shyh-Shin Chiou ; Jiunn-Ming Sheen ; Shin-Nan Cheng ; Shu-Huey Chen ; Yu-Hsiang Chang ; Wan-Ling Ho ; Yu-Hua Chao ; Rong-Long Chen ; Bow-Wen Chen ; Jinn-Li Wang ; Yuh-Lin Hsieh ; Yu-Mei Liao ; Shang-Hsien Yang ; Wan-Hui Chang ; Yu-Mei Y. Chao and Der-Cherng Liang
• 刊名：Pediatric Blood & Cancer
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：64
• 期：2
• 页码：234-241
• 全文大小：823K
• ISSN：1545-5017

文摘

Reinduction therapy has improved the outcomes in children with acute lymphoblastic leukemia (ALL). We sought to determine the optimal course(s) of reinduction therapy for standard-risk (SR, or “low-risk” in other groups) patients. Also, we evaluated outcomes using triple intrathecal therapy without cranial radiation (CrRT) for central nervous system (CNS) preventive therapy.